These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29781848)

  • 1. Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations.
    Renaud S; Seitlinger J; Lawati YA; Guerrera F; Falcoz PE; Massard G; Ferri L; Spicer J
    Ann Surg; 2019 Dec; 270(6):1170-1177. PubMed ID: 29781848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.
    Renaud S; Guerrera F; Seitlinger J; Costardi L; Schaeffer M; Romain B; Mossetti C; Claire-Voegeli A; Filosso PL; Legrain M; Ruffini E; Falcoz PE; Oliaro A; Massard G
    Oncotarget; 2017 Jan; 8(2):2514-2524. PubMed ID: 27911859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.
    Renaud S; Romain B; Falcoz PE; Olland A; Santelmo N; Brigand C; Rohr S; Guenot D; Massard G
    Br J Cancer; 2015 Feb; 112(4):720-8. PubMed ID: 25688918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.
    Renaud S; Schaeffer M; Falcoz PE; Seitlinger J; Romain B; Voegeli AC; Legrain M; Reeb J; Santelmo N; Rohr S; Brigand C; Olland A; Guenot D; Massard G
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):255-262. PubMed ID: 28186237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
    Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
    J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
    Schweiger T; Hegedüs B; Nikolowsky C; Hegedüs Z; Szirtes I; Mair R; Birner P; Döme B; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.
    Kim HS; Heo JS; Lee J; Lee JY; Lee MY; Lim SH; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim ST; Park JO; Lim HY; Choi YS; Kwon WI; Kim HC; Park YS
    BMC Cancer; 2016 Feb; 16():120. PubMed ID: 26887348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS mutation in lung metastases from colorectal cancer: prognostic implications.
    Ghidini M; Personeni N; Bozzarelli S; Baretti M; Basso G; Bianchi P; Tronconi MC; Pressiani T; Grizzi F; Giordano L; Malesci A; Alloisio M; Laghi L; Santoro A; Rimassa L
    Cancer Med; 2016 Feb; 5(2):256-64. PubMed ID: 26715198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
    Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
    J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer.
    Renaud S; Seitlinger J; St-Pierre D; Garfinkle R; Al Lawati Y; Guerrera F; Ruffini E; Falcoz PE; Massard G; Ferri L; Spicer J
    Eur J Cardiothorac Surg; 2019 May; 55(5):948-955. PubMed ID: 30508167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
    Deboever N; Bayley EM; Eisenberg MA; Hofstetter WL; Mehran RJ; Rice DC; Rajaram R; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Bednarski BK; Morris VK; Antonoff MB
    J Thorac Cardiovasc Surg; 2024 Mar; 167(3):814-819.e2. PubMed ID: 37495170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of segmentectomy and wedge resection for pulmonary metastases from colorectal cancer.
    Shiono S; Okumura T; Boku N; Hishida T; Ohde Y; Sakao Y; Yoshiya K; Hyodo I; Mori K; Kondo H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):504-510. PubMed ID: 27773868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study.
    Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J
    Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.
    Huang J; Zang Q; Wen Y; Pan Z; Yao Z; Huang M; Huang J; Chen J; Wang R
    Crit Rev Oncol Hematol; 2021 Apr; 160():103308. PubMed ID: 33753248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR).
    Hernández J; Molins L; Fibla JJ; Heras F; Embún R; Rivas JJ;
    Ann Oncol; 2016 May; 27(5):850-5. PubMed ID: 27113270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival?
    Menna C; Berardi G; Tierno SM; Andreetti C; Maurizi G; Ciccone AM; D'Andrilli A; Cassiano F; Poggi C; Diso D; Venuta F; Rendina EA; Ibrahim M
    Ann Thorac Surg; 2018 Aug; 106(2):421-427. PubMed ID: 29605599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma.
    Renaud S; Falcoz PE; Olland A; Schaeffer M; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):215-21. PubMed ID: 25358477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.